Revealing the structural and molecular interaction landscape of the favipiravir-RTP and SARS-CoV-2 RdRp complex through integrative bioinformatics: Insights for developing potent drugs targeting SARS-CoV-2 and other viruses

BACKGROUND: The global research community has made considerable progress in therapeutic and vaccine research during the COVID-19 pandemic. Several therapeutics have been repurposed for the treatment of COVID-19. One such compound is, favipiravir, which was approved for the treatment of influenza vir...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakraborty, Chiranjib, Bhattacharya, Manojit, Saha, Abinit, Alshammari, Abdulrahman, Alharbi, Metab, Saikumar, G., Pal, Soumen, Dhama, Kuldeep, Lee, Sang-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170963/
https://www.ncbi.nlm.nih.gov/pubmed/37196368
http://dx.doi.org/10.1016/j.jiph.2023.05.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170963/
https://www.ncbi.nlm.nih.gov/pubmed/37196368
http://dx.doi.org/10.1016/j.jiph.2023.05.010

Ejemplares similares